Skip to main content
. 2021 Jun 17;16(6):e0253393. doi: 10.1371/journal.pone.0253393

Fig 4. Population coverage analysis of finalized epitopes (MHC-I and MHC-II).

Fig 4

Europe, England, North America, United States, and West Africa showed the highest (100%) population coverage.